Af­ter the ap­plause: New ef­fi­ca­cy ex­pec­ta­tions in urothe­lial can­cer af­ter Pad­cev-Keytru­da da­ta re­veal

Urothe­lial can­cer on­col­o­gist Matthew Gal­sky has trou­ble re­mem­ber­ing the last time there was a stand­ing ova­tion for clin­i­cal tri­al da­ta at a med­ical con­fer­ence. But …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER